Department of Respiratory Medecine, Arrazi Hospital, Mohammed VI University Hospital Center, Faculty of Medecine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
Department of Respiratory Medecine, Arrazi Hospital, Mohammed VI University Hospital Center, Faculty of Medecine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco; Pneumo-phtisiology Department, CHU Brazzaville, Brazzaville, Republic of Congo.
Respir Med. 2021 Sep;186:106512. doi: 10.1016/j.rmed.2021.106512. Epub 2021 Jun 18.
The 2019 Coronavirus disease (COVID-19) has caused a global distress. However, its psychological impact on patients is unclear. We aim to determine the mental health status and explore related factors of anxiety and depression among patients with (COVID-19).
This is a cross-sectional descriptive survey conducted among COVID-19 patients at the Mohammed VI University Hospital Centre in Marrakech over a period of four months. We assessed symptoms of depression and anxiety using the Arabic version of the Hospital Anxiety and Depression Scale (HADS) on admission. The significance threshold used for any data comparison test was the value of p < 0.05.
A total of 103 participants were included. The average age was 44, 17 ± 17, 19 years. About 54,4% of the subjects were male. Of the 103 participants, 36.89% and 23.30% patients with COVID-19 had symptoms of anxiety or depression; respectively. The mean score of anxiety subscale and depression subscale for all patients was 6.45 ± 4.29 and 5.38 ± 4.47, respectively. The bivariate analysis showed that age (p=0, 0004; p=0, 0002), oxygen saturation level (p=0, 0003; p=0, 0059), hospital stay (p <0, 0001; p <0, 0001) and family infection with SARS-CoV-2 (p=0, 0094; p=0, 0023) were associated with anxiety and depression respectively for COVID-19 patients. Moreover, gender (p=0, 0119) was associated with depression.
There is an increasing level of anxiety and depression in hospitalized patients with COVID-19. Mental concern and appropriate intervention remain an important part of clinical care for those who are at risk.
2019 年冠状病毒病（COVID-19）在全球范围内造成了困扰。然而，其对患者的心理影响尚不清楚。我们旨在确定 COVID-19 患者的心理健康状况，并探讨焦虑和抑郁的相关因素。
这是一项在马拉喀什穆罕默德六世大学医院中心进行的为期四个月的 COVID-19 患者的横断面描述性调查。我们在入院时使用阿拉伯语版医院焦虑和抑郁量表（HADS）评估抑郁和焦虑症状。任何数据比较测试的显著性阈值均为 p<0.05。
共纳入 103 名参与者。平均年龄为 44 岁，17±17 岁，19 岁。约 54.4%的受试者为男性。在 103 名参与者中，COVID-19 患者中有 36.89%和 23.30%分别出现焦虑或抑郁症状。所有患者的焦虑分量表和抑郁分量表的平均得分分别为 6.45±4.29 和 5.38±4.47。单变量分析显示，年龄（p=0.0004;p=0.0002）、氧饱和度水平（p=0.0003;p=0.0059）、住院时间（p<0.0001;p<0.0001）和家庭感染 SARS-CoV-2（p=0.0094;p=0.0023）与 COVID-19 患者的焦虑和抑郁分别相关。此外，性别（p=0.0119）与抑郁相关。
住院 COVID-19 患者的焦虑和抑郁水平呈上升趋势。心理关注和适当的干预仍然是高危人群临床护理的重要组成部分。
